Primary Record
Relugolix
- In stock
- 2,921 g
- Purity
- 99.4 %
- CAS
- 737789-87-6
Compound Identifiers & Properties
- CAS
- 737789-87-6
- PubChem CID
- 10348973
- SMILES
- CN(C)CC1=C(SC2=C1C(=O)N(C(=O)N2CC3=C(C=CC=C3F)F)C4=NN=C(C=C4)OC)C5=CC=C(C=C5)NC(=O)NOC
- Canonical SMILES
- CONC(=O)Nc1ccc(-c2sc3c(c2CN(C)C)c(=O)n(-c2ccc(OC)nn2)c(=O)n3Cc2c(F)cccc2F)cc1
Names & Synonyms
- Relugolix
- Orgovyx
- TAK-385
- 737789-87-6
- relumina
- relugolixum
- Orgovyx (TN)
- TAK 385
- Relugolix (Standard)
- Relugolix [USAN:INN]
- RefChem:57784
- RELUGOLIX [INN]
- RELUGOLIX [JAN]
- Relugolix(TAK-385)
- RELUGOLIX [USAN]
- TAK385
- Relugolix(TAK-385)?
- D0F2WP
- UNII-P76B05O5V6
- RELUGOLIX [WHO-DD]
- P76B05O5V6
- C29H27F2N7O5S
- CHEMBL1800159
- Relugolix (JAN/USAN/INN)
- SCHEMBL778416
- DTXSID40224167
- TAK-385/TAK385
- GTPL5586
- orb1303979
- RELUGOLIX [ORANGE BOOK]
- MYFEMBREE COMPONENT RELUGOLIX
- SCHEMBL29386968
- DTXCID40146658
- RVT 601
- AOMXMOCNKJTRQP-UHFFFAOYSA-N
- MFCD25976856
- GLXC-10592
- HMS5085J09
- 1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-3-methoxyurea
- AMY27916
- BCP21587
- EX-A1083
- TAK-385; RVT-601
- BDBM50347982
- EBC-17169
- HY-16474R
- s5808
- ZINC43206033
- AKOS027440398
- CS-5917
- DB11853
- SB16721
- CID10348973
- AC-35863
- BP-44043
- BS-18032
- CID 10348973
- CID:10348973
- HY-16474
- SID:202535644
- NS00072569
- J3.724.581J
- D10888
- A857822
- C561634
- EN300-19854622
- Ryeqo (relugolix-estradiol-norethisterone acetate)
- Q21099000
- B0084-462794
- 1-[4-[1-[(2,6-difluorophenyl)methyl]-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-3-methoxyurea
- N-(4-(1-((2,6-Difluorophenyl)methyl)-5-((dimethylamino)methyl)-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno(2,3-d)pyrimidin-6-yl)phenyl)-N'-methoxyurea
- 1-(4-{1-[(2,6-difluorophenyl)methyl]-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1H,2H,3H,4H-thieno[2,3-d]pyrimidin-6-yl}phenyl)-3-methoxyurea
- Urea, N-(4-(1-((2,6-difluorophenyl)methyl)-5-((dimethylamino)methyl)-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno(2,3-d)pyrimidin-6-yl)phenyl)-N'-methoxy-
- 1-(2,6-Difluorobenzyl)-3-(6-methoxypyridazine-3-yl)-5-[(dimethylamino)methyl]-6-[4-[(methoxyaminocarbonyl)amino]phenyl]thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione
- 1-(4-(1-((2,6-difluorophenyl)methyl)-5-((dimethylamino)methyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1H,2H,3H,4H-thieno(2,3-d)pyrimidin-6-yl)phenyl)-3-methoxyurea
- 1-(4-(1-((2,6-difluorophenyl)methyl)-5-(dimethylaminomethyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxothieno(4,5-e)pyrimidin-6-yl)phenyl)-3-methoxyurea
- 1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno(2,3-d)pyrimidin-6-yl)phenyl)-3-methoxyurea
- 1-(4-{1-[(2,6-Difluorophenyl)methyl]-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl}phenyl)-3-methoxyurea
- 1-[4-[1-[(2,6-difluorophenyl)methyl]-5-(dimethylaminomethyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxothieno[4,5-e]pyrimidin-6-yl]phenyl]-3-methoxyurea
- 1-[4-[1-[(2,6-difluorophenyl)methyl]-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-thieno[2,3-d]pyrimidin-6-yl]phenyl]-3-methoxy-urea
- 1-{4-[1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea
- N-(4-{1-[(2,6-Difluorophenyl)methyl]-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl}phenyl)-N'-methoxyurea
- N-[4-[1-[(2,6-Difluorophenyl)methyl]-5-[(dimethylamino)methyl]-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-N'-methoxyurea
- N-[4-[1-[(2,6-Difluorophenyl)methyl]-5-[(dimethylamino)methyl]-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-N'-methoxyurea; 1-[4-[1-[(2,6-Difluorophenyl)methyl]-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-3-methoxyurea; Orgovyx; RVT 601; TAK 385
- Urea, N-[4-[1-[(2,6-difluorophenyl)methyl]-5-[(dimethylamino)methyl]-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-N'-methoxy-